Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-05-06
$115.24M
$-347.19M
$-310.42M
-$1.06
$1.01B
$3.07B
$-1.31B
$1.06B
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Core Scientific reported revenue of $115.2 million, up 44.9% year-over-year. Net loss was $347.2 million, compared to a loss of $133.2 million in the prior year quarter. Operating loss widened to $310.4 million from $47.0 million. Diluted EPS was -$1.06, down from -$0.37.
- •Revenue increased 44.9% YoY to $115.2 million.
- •Net loss widened to $347.2 million from $133.2 million.
- •Operating loss expanded to $310.4 million from $47.0 million.
- •Diluted EPS was -$1.06, compared to -$0.37 in Q1 FY2025.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.